Aptose Biosciences financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M
GM % Gross Margin %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
C$-702.07 C$-540.05 C$-10.05 C$-18.45 C$-21.90 C$-10.03 C$-14.25 C$-10.75 C$-12.62 C$-13.80 C$-9.22 C$-10.29 C$0.00
Div. Dividends
C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0.48m 0.48m 0.58m 0.6m 0.7m 0.83m 1.31m 1.76m 3.52m 4.95m 11.66m 12.05m 13.76m 26.9m 37.77m 76.11m 88.86m 5.93m 6.15m 0m 15.72m
OCF Operating Cash Flow
C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$-11.51M C$-9.89M C$-12.39M C$-10.22M C$-23.21M C$-21.56M C$-33.89M C$-43.30M C$-32.32M C$-44.59M C$0.00M
FCF Free Cash Flow
C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$-11.86M C$-10.15M C$0.00M C$-10.23M C$-31.49M C$-29.84M C$-42.64M C$-54.85M C$-44.48M C$-44.61M C$0.00M
FCFS Free Cash Flow Per Share
C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$-1.02 C$-0.85 C$-0.97 C$-0.46 C$-0.70 C$-0.43 C$-0.42 C$-0.49 C$-5.26 C$-6.61 C$0.00